A new isoflavone, 4-g g,g g-dimethylallyloxy-5,7,2,5-tetramethoxyisoflavone, brandisianin A (1), was isolated from the leaves of Millettia brandisiana, along with one synthetically known isoflavone, 7,4-di-O-prenylgenistein (2) and twelve known compounds. The structures were elucidated on the basis of extensive spectroscopic analysis. Two isolated compounds were tested for anti-inflammatory activity; 12a-hydroxy-a a-toxicarol (11) showed significant anti-inflammatory activity.
Notes
Millettia brandisiana KURZ, a member of the Leguminosae, is a medium-sized tree growing throughout Thailand; 1) however, its medicinal use is unknown. Chemical investigations of a few species of genus Millettia in Thailand resulted in the isolation of several flavonoids, some of which showed antiviral and anti-inflammatory activities.
2) There have been no previous studies on the chemical composition of the leaves of M. brandisiana. In an earlier report, we described the isolation of four rotenoids from the hexane extract of the flowers of M. brandisiana. 3) In the present investigation, the ethyl acetate extract of the leaves yielded a new isoflavone, 4Ј-g,g-dimethylallyloxy-5,7,2Ј,5Ј-tetramethoxyisoflavone (1) , as well as a synthetically known isoflavone, 7,4Ј-di-O-prenylgenistein (2), 4) three known isoflavones, eight known rotenoids, and a sterol. The structures of the known compounds were determined to be robustigenin (3), 5) toxicarol isoflavone (4), 6) viridiflorin (5), 7) sermundone (6), 8) 6-deoxyclitoriacetal (7), 9) 6a,12a-dehydrosermundone (8), 10, 11) stemonal (9), 12) a-toxicarol (10), 13) 12a-hydroxy-atoxicarol (11), 14) 6a,12a-dehydro-a-toxicarol (12), 15) 6-hydroxy-6a,12a-dehydro-a-toxicarol (13) , 16) and b-sitosterol (14) 17) by analysis of physical and spectroscopic evidence. In addition, the anti-inflammatory activity using ethyl phenylpropiolate-induced ear edema in rats of two pure compounds isolated was also studied. TLC screening assay of free radical scavenging activity of the isolated flavonoids is also described.
Results and Discussion
Purification of the ethyl acetate extract of the leaves of M. brandisiana gave a new isoflavone, 4Ј-g,g-dimethylallyloxy-5,7,2Ј,5Ј-tetramethoxyisoflavone (1). The molecular formula of 1 was determined to be C 24 a-Toxicarol (10), 12a-hydroxy-a-toxicarol (11) , and 6a,12a-dehydro-a-toxicarol (12) were previously evaluated for their potential chemopreventive properties in a mouse mammary organ culture (MMOC) model; only a-toxicarol (10) was found to exhibit inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced pre-neoplastic lesions (80% at a dose of 10 mg/ml).
13) 6-Deoxyclitoriacetal (7) was reported to possess strong cytotoxic activity against culture P-338 lymphocytic leukemia cells. 9) Compound 7 also showed smooth muscle relaxant activity through a nonspecific mechanism by interference with intracellular calcium metabolism. 18) Two rotenoids, 6-deoxyclitoriacetal (7) and stemonal (9), were studied for anti-inflammatory activity. Compound 7 was shown to possess higher anti-inflammatory activity than 9 using a capillary permeability assay, a typical model of firststage inflammatory reactions. 19) In our earlier report, 6-deoxyclitoriacetal (7) and 12a-hydroxy-a-toxicarol (11) showed no activity against the tested bacteria and yeasts at the highest concentration (128 mg/ml).
3) Since several compounds were isolated in the present investigation in only low yields, the compound quantities available did not permit any biological assays.
In our present study, compounds 7 and 11, which were isolated as the major components, were tested for anti-inflammatory activity; the results are shown in Table 2 . Application of ethyl phenylpropiolate (EPP) topically on rat ears produced marked edema formation. At all assessment times compounds 7 and 11 at the dose of 1 mg per ear significantly inhibited the ear edema formation. When the intensity of the inhibitory effect of the two test compounds was compared, compound 11 showed highest intensity. Phenylbutazone at the dose of 1 mg per ear, used as positive control, significantly reduced the edema formation at all assessment times. The results of the present study revealed the anti-inflammatory activity of compounds 7 and 11 on acute phase of inflammation. Edema caused by topically applied EPP is due to vasodilatation and increased vascular permeability. This event is caused by the release of various inflammatory mediators such as histamine, 5-HT, and PGs. 20) Our test compounds markedly inhibited ear edema formation induced by EPP. It is suggested that compounds 7 and 11 probably exerted anti-inflammatory activity through the inhibition of the above inflammatory mediators of acute inflammation.
All isolated flavonoids were also evaluated for free radical scavenging activity using TLC screening assay. Only three compounds, robustigenin (3), viridiflorin (5), and 12a-hy- droxy-a-toxicarol (11), revealed DPPH radical scavenging activity and appeared as yellow spots against a purple background. Two isoflavones, robustigenin (3) and toxicarol isoflavone (4), were isolated in small amounts from the hexane-soluble part of the EtOAc extract. From both the hexane-soluble and hexane-insoluble parts of the extract a number of corresponding rotenoids and dehydrorotenoids were obtained with 6-deoxyclitoriacetal (7) and 12a-hydroxy-a-toxicarol (11) as the main components. The isolation of these metabolites is in accordance with the biosynthetic pathway of these compounds. Although 7,4Ј-di-O-prenylgenistein (2) was earlier synthesized, this is the first time it has been found as a naturally occurring compound. It is interesting to note that M. brandisiana is the first Thai Millettia species to produce isoflavones and rotenoids; other species of Millettia in Thailand have yielded only flavones and chalcones. 2, 22) In addition, 12a-hydroxy-a-toxicarol (11) seems worthy of additional testing further to evaluate its potential as an anti-inflammatory agent.
Experimental
General Experimental Procedures Melting points were determined by a Kofler hot stage apparatus. UV spectra were obtained on a Hewlett Packard 8453 UV-VIS spectrophotometer. IR spectra were recorded on a Perkin-Elmer GX FT-IR spectrophotometer.
1 H-and 13 C-NMR spectra were recorded in CDCl 3 solutions on a Bruker AVANCE (300 MHz) spectrometer using TMS as internal standard. HMQC and HMBC spectra were acquired using the standard Bruker software. Optical rotations were measured on a JASCO P1010 digital polarimeter. Mass spectra were obtained from a Bruker MicroTOF spectrometer. Vacuum liquid chromatography (VLC) and column chromatography (CC) were performed on silica gel 60 (70-230 mesh, Merck). TLC and preparative TLC (PLC) were conducted on silica gel plates (60F 254 , Merck).
Plant Material The leaves of M. brandisiana were collected at Silpakorn University, Nakorn Pathom in June 2003. A voucher specimen (SUMB603) was identified by Assoc. Prof. Nijsiri Ruangrungsi and deposited at the Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Extraction and Isolation The dried leaves of M. brandisiana (1.27 kg) were extracted with EtOH (5 lϫ3) at room temperature. The combined extract was concentrated to dryness to give 186.7 g of residue. The EtOH extract was sequentially partitioned between organic solvents and water to yield EtOAc extract (79.4 g), n-butanol extract (30.6 g), and water extract (76.5 g). The EtOAc extract was further dissolved in hexane to afford a hexane-soluble fraction (22.3 g) and a hexane-insoluble fraction (57.1 g). Separation of the hexane-soluble fraction by VLC using gradient hexane-EtOAc gave 12 fractions (A1-A12). The combined A3 and A4 (5.06 g) was subjected to CC with gradient hexane-acetone (9 : 1, 8 : 2, 7 : 3) to give 4 fractions (B1-B4). B1 (284.5 mg) was purified by PLC (hexane-CH 2 Cl 2 , 1 : 9) to afford 11 (117.1 mg). B2 (177.1 mg) was purified by PLC (hexane-CH 2 Cl 2 -EtOAc, 4 : 1 : 1) to yield 13 (10.1 mg). B3 (143.4 mg) and B4 (46.6 mg) were purified by PLC (CH 2 Cl 2 -MeOH, 30 : 1) to give 7 (34.3 mg) and 9 (3.9 mg). The combined A5 and A6 (1.79 g) was purified by CC with gradient hexane-acetone (9 : 1, 8 : 2, 7 : 3) to afford 2 fractions (C1, C2) that were further purified by PLC (hexane-acetone, 3 : 1) to yield 10 (21 mg) and 11 (178.8 mg). A7 (1.70 g) was purified by CC with gradient hexane-acetone (8 : 2, 7 : 3) to give 7 (373.6 mg). Repetitive PLC of A8 (1.54 g) with hexane-acetone (3 : 1) afforded 4 (2.6 mg), 3 (7.2 mg), 11 (309.2 mg), and 7 (186.8 mg). The combined A9 and A10 (1.86 g) was subjected to CC with gradient CH 2 Cl 2 -MeOH (40 : 1, 30 : 1, 20 : 1, 10 : 1) to give 5 fractions (D1-D5). D3 (86.1 mg) was purified by PLC (hexane-acetone-MeOH, 3 : 1 : 0.4) to afford 9 (3.4 mg). Purification of D4 (303.5 mg) by repeated PLC (hexane-acetone-MeOH, 3 : 1 : 0.8) gave 1 (7 mg).
Separation of the hexane-insoluble fraction (57.1 g) by VLC using gradient hexane-EtOAc gave 17 fractions (E1-E17). The combined E1, E2, and E3 (1.96 g) was subjected to CC with gradient hexane-EtOAc and further purified by PLC (hexane-acetone, 3 : 1) to yield 12 (18.3 mg) and 10 (7.2 mg). E6 (10.09 g) was separated on CC with gradient hexane-EtOAc to afford 11 fractions (F1-F11) . F3 (311.3 mg) was purified by CC with CH 2 Cl 2 and further crystallized from acetone to give 14 (50.2 mg). F6 (3.36 g) was purified by CC with gradient hexane-EtOAc to yield 6 fractions (G1-G6). G3 (874 mg) was purified by PLC (hexane-CH 2 Cl 2 -EtOAc, 6 : 1 : 1) to afford 10 (31.5 mg). Repetitive PLC of G4 (411 mg) using hexane-CH 2 Cl 2 -EtOAc (6 : 1 : 1) and hexane-acetone (3 : 1) gave 6 (2.7 mg). F9 (1.15 g) was purified by CC using CH 2 Cl 2 to yield 7 (890.4 mg). Purification of F10 (617 mg) by CC with CH 2 Cl 2 afforded 11 (49.1 mg), 7 (251.6 mg), and 5 (10 mg). The combined E4, E5, and E7 (10.9 g) was separated on CC using gradient hexane-acetone (8 : 2, 7 : 3) to give 10 fractions (H1-H10). Repeated PLC of H1 (590.5 mg) with hexane-acetone (3 : 1) yielded 2 (17.4 mg 20) because of the thin skin of the ear and being easy to induce edema by irritant.
Ethyl Phenylpropiolate (EPP)-Induced Ear Edema in Rats Topical anti-inflammatory activity of compounds 7 and 11 was assessed by the method described by Brattsand et al. 20) Male rats of 40-60 g body weight were used.
The inflammogen EPP was dissolved in acetone and ear edema was induced by topical application of EPP at a dose of 1 mg/20 ml/ear to the inner and outer surfaces of both ears using an automatic microliter pipette. Test substances also dissolved in acetone (20 ml/ear) were administered topically just before the inflammogen. The thickness of ear was measured with vernier calipers before and at 15, 30, 60, and 120 min after edema induction. The effect of the test substances on the ear edema was compared with that of the vehicle-control group, and the percent inhibition was calculated.
Statistical Analysis The data from the experiment were expressed as meanϮS.E.M. Statistical comparison between groups was analyzed by oneway analysis of variance (ANOVA) and post hoc least-significant difference (LSD) test. p values, Ͻ0.05 were considered significant.
Evaluation of Free Radical Scavenging Activity TLC Screening Assay Test samples were spotted on a TLC plate, and development was performed with a suitable solvent. After drying, the TLC plate was sprayed with 0.3% solution of 1,1-diphenyl-2-picrylhydrazyl (DPPH) in MeOH and left 30 min before visual examination. 21) Constituents possessing free radical scavenging activity appeared as yellow spots against a purple background.
